|
COQ7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
3.07539999999662E-06 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
1.207690E-04 |
| Stage1-vs-Stage3 |
2.215600E-01 |
| Stage1-vs-Stage4 |
8.460000E-02 |
| Stage2-vs-Stage3 |
1.388470E-04 |
| Stage2-vs-Stage4 |
7.64680000000517E-05 |
| Stage3-vs-Stage4 |
5.230400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
5.8989999999981E-05 |
| Normal-vs-Asian |
1.62458935193399E-12 |
| Caucasian-vs-AfricanAmerican |
1.421570E-02 |
| Caucasian-vs-Asian |
8.466400E-01 |
| AfricanAmerican-vs-Asian |
5.576400E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62458935193399E-12 |
| Male-vs-Female |
3.339200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
1.67586999999525E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.268400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.184600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.361800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.497400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.191400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.616400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.962200E-04 |
| Classical-VS-Follicular |
1.61720000002585E-06 |
| Classical-VS-Other |
2.388200E-01 |
| Classical-VS-Normal |
1.62458935193399E-12 |
| Tall-VS-Follicular |
2.33340002875337E-09 |
| Tall-VS-Other |
7.352800E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
1.410270E-02 |
| Follicular-VS-Normal |
2.21220000096167E-08 |
| Other-VS-Normal |
1.33189999995675E-06 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.11022302462516E-16 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
4.010400E-04 |
|
|
